The Science of Basel Startup Companies

20th January 2022 Basel, Switzerland

Home

Program

Flyer

Morning Session

    08:30 – 08:35 Opening Remarks 

Keynote lecture

8.35 – 9.30

NBE Therapeutics: Next generation antibody-drug conjugates

Ulf Grawunder

 

    09:30 – 09:45 Break

09:45 – 11:45 How to start your new venture

Engaging, incubating & accelerating:

09:45 – 10:15

Basel Area & BaseLaunch: Early steps to build a successful biotech venture.

Martyna Wroblewska

Financing:

10:15 – 10:45

Synendos Therapeutics – Financing a Biotech Start Up: from inception to clinical stage and beyond

Simon Russell

Venture Capital:

10:45 – 10:55

Versant Ventures

Alexander Mayweg

Venture Capital:

10:55 – 11:05

Novartis Venture Fund

Florian Müllershausen

   11:05 – 11:45 Panel Discussion

   11:45 – 13:30 Lunch Break

Afternoon Session

   13:30 – 16:55 Company Science Presentations

13:30 – 13:55

Tolremo: Preventing Drug Resistance in Cancer

Stefanie Flückiger-Mangual

13:55 – 14:20

Cellestia – Targeting Transcription Factors for treating human cancers and auto immune and inflammatory diseases

Rajwinder Lehal  

14:20 – 14:45

SpiroChem: SPEED, SPEED, SPEED: can you synthesize fast(er) please? On the importance of synchronizing discovery chemistry with biotech’s aggressive timelines

Thomas Fessard

14:45 – 15:10

Bright Peak Therapeutics: Developing Next-Generation Cytokine Therapeutics

Bertolt Kreft

   15:10 – 15:40 Break

15:40 – 16:05

Saverna Therapeutics: Regulation of microRNA Biogenesis with Low Molecular Weight Molecules

Kamal Azzaoui

16:05 – 16:30

FoRx Therapeutics: Targeting DNA replication stress for anticancer therapies

Sotirios Sotiriou

16:30 – 16:55

Monte Rosa Therapeutics: Molecular Glue Degraders: From Serendipity to Rational Design

Bernhard Fasching

    
  16:55-17:00 Closing Remarks/End of Symposium